Sellas Life Sciences Group Inc (SLS) returns
Sellas Life Sciences Group returns over 5 years
$1,000 invested in Sellas Life Sciences Group five years ago was worth $1,114 at the close on October 30, 2026, with dividends reinvested: an average return of 2.2% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -21.4% | — | $786.35 | -0.9% |
| 3 months | -5.9% | — | $940.72 | +2.1% |
| Year to date | +156.8% | — | $2,568 | +11.7% |
| 1 year | +406.8% | — | $5,068 | +12.4% |
| 3 years | +734.5% | +102.8% | $8,345 | +88.5% |
| 5 years | +11.4% | +2.2% | $1,114 | +76.0% |
Sellas Life Sciences Group return by calendar year
| Year | SLS | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +156.8% | +11.7% | +145.1% |
| 2025 | +262.5% | +17.7% | +244.8% |
| 2024 | -1.9% | +24.9% | -26.8% |
| 2023 | -55.1% | +26.2% | -81.3% |
| 2022 | -57.3% | -18.2% | -39.2% |
| 2021 | -4.8% | +28.7% | -33.6% |
| 2020 | +35.1% | +18.4% | +16.7% |
| 2019 | -93.0% | +31.2% | -124.2% |
| 2018 | -84.2% | -4.6% | -79.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: SLS financials
No forecast, no recommendation. This page describes Sellas Life Sciences Group Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.